Preferred Label : asfotase alfa;
MeSH note : comprising the TNSALP ectodomain, the constant region of the human IgG1 Fc domain,
and a terminal deca-aspartate motif for bone targeting;
CISMeF synonym : ENB-0040;
Is substance : O;
UNII : Z633861EIM;
Origin ID : C570710;
UMLS CUI : C3490795;
ATC code(s)
CISMeF manual mappings
MeSH indexing information
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia
---
https://www.has-sante.fr/jcms/p_3455973/fr/strensiq-asfotase-alfa-hypophosphatasie
2023
false
false
false
France
hypophosphatasia
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
asfotase alfa
hypophosphatasia
evaluation of the transparency committee
asfotase alfa
---
http://www.has-sante.fr/portail/jcms/c_2621689/fr/strensiq
2016
false
false
false
France
French
treatment outcome
asfotase alfa
asfotase alfa
hypophosphatasia
enzyme replacement therapy
orphan drug production
injections, subcutaneous
asfotase alfa
evaluation of the transparency committee
insurance, health, reimbursement
Product containing asfotase alfa in parenteral dose form (medicinal product form)
alkaline phosphatase
immunoglobulin G
recombinant fusion proteins
alkaline phosphatase
immunoglobulin G
recombinant fusion proteins
---
https://www.ema.europa.eu/medicines/human/EPAR/Strensiq
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
asfotase alfa
asfotase alfa
hypophosphatasia
enzyme replacement therapy
orphan drug production
injections, subcutaneous
product surveillance, postmarketing
drug monitoring
pregnancy
breast feeding
drug evaluation, preclinical
asfotase alfa
Product containing asfotase alfa in parenteral dose form (medicinal product form)
alkaline phosphatase
immunoglobulin G
recombinant fusion proteins
alkaline phosphatase
immunoglobulin G
recombinant fusion proteins
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00190
2015
false
false
false
false
Canada
French
drug information
Product containing asfotase alfa in parenteral dose form (medicinal product form)
asfotase alfa
asfotase alfa
alkaline phosphatase
immunoglobulin G
recombinant fusion proteins
---